tiprankstipranks
Trending News
More News >
China Regenerative Medicine International Limited (HK:8158)
:8158
Hong Kong Market

China Regenerative Medicine International Limited (8158) Financial Statements

Compare
0 Followers

China Regenerative Medicine International Limited Financial Overview

China Regenerative Medicine International Limited's market cap is currently HK$197.76M. The company's EPS TTM is HK$0.058; its P/E ratio is 11.13; China Regenerative Medicine International Limited is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueHK$ 90.62MHK$ 69.49MHK$ 41.54MHK$ 282.90MHK$ 182.14M
Gross ProfitHK$ 57.65MHK$ 19.42MHK$ 37.62MHK$ 67.73MHK$ 41.81M
Operating IncomeHK$ 18.88MHK$ -106.72MHK$ 12.29MHK$ 64.59MHK$ -37.53M
EBITDAHK$ 29.84MHK$ -95.40MHK$ 14.44MHK$ 64.66MHK$ -121.84M
Net IncomeHK$ 17.75MHK$ -107.70MHK$ 4.55MHK$ 51.83MHK$ -404.23M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 57.45MHK$ 3.33MHK$ 1.85MHK$ 9.93MHK$ 4.77M
Total AssetsHK$ 135.71MHK$ 185.90MHK$ 275.91MHK$ 259.14MHK$ 152.49M
Total DebtHK$ 53.69MHK$ 50.19MHK$ 72.01MHK$ 35.82MHK$ 43.19M
Net DebtHK$ 30.99MHK$ 46.86MHK$ 70.16MHK$ 25.89MHK$ 38.43M
Total LiabilitiesHK$ 110.51MHK$ 174.10MHK$ 172.00MHK$ 147.41MHK$ 207.64M
Stockholders' EquityHK$ 25.20MHK$ 11.79MHK$ 103.92MHK$ 111.73MHK$ 58.13M
Cash Flow
Free Cash FlowHK$ 17.68MHK$ 6.06MHK$ -20.25MHK$ -3.83MHK$ -397.74M
Operating Cash FlowHK$ 18.30MHK$ 6.34MHK$ -17.65MHK$ -3.02MHK$ -397.74M
Investing Cash FlowHK$ -622.00KHK$ -262.00KHK$ -2.59MHK$ 9.27MHK$ 326.96M
Financing Cash FlowHK$ 2.37MHK$ -7.36MHK$ 7.32MHK$ -1.39MHK$ 67.37M
Currency in HKD

China Regenerative Medicine International Limited Earnings and Revenue History

China Regenerative Medicine International Limited Debt to Assets

China Regenerative Medicine International Limited Cash Flow

China Regenerative Medicine International Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis